Cancer Diagnoses Rise as Treatments Improve Survival Rates, Experts Explain
In recent years, many people feel that cancer diagnoses have become more common among their acquaintances. This perception is supported by data showing an increase in cancer diagnoses compared to previous decades, but it also comes with encouraging news: fewer people are dying from cancer today than before. Dr. Mikael Skars, head of hematology at the Sylvester Cancer Center at the University of Miami, explained in a Washington Post article that while cancer incidence has risen, mortality rates have significantly declined due to advances in detection and treatment.
According to U.S. statistics, cancer diagnoses increased from about 400 cases per 100,000 people in 1975 to 456 cases per 100,000 in 2023. Meanwhile, the age-adjusted death rate dropped from 201 deaths per 100,000 in 1999 to 142 in 2023. This means more people are diagnosed but also survive longer after diagnosis. Cancer is caused by uncontrolled cell division, often due to DNA errors from random mutations, environmental exposures like UV radiation and smoking, or inherited mutations such as BRCA1 and BRCA2. Since cancer risk rises with age, longer life expectancy contributes to more diagnoses.
The rise in diagnoses is also due to improved detection methods, including more sensitive imaging, blood tests for early markers, and screening programs that catch tumors earlier. Additionally, some diseases previously not classified as cancer, like myelodysplastic syndromes, are now included, increasing reported cases. However, not all cancer types are increasing; for example, colorectal cancer rates have declined in older populations due to screening and prevention efforts, though they have risen among younger adults.
The decline in cancer mortality is attributed to early detection and revolutionary treatments. Targeted therapies focus on specific genetic mutations in tumors, such as HER2 in breast cancer and ALK in lung cancer. Immunotherapy, which helps the immune system recognize and attack cancer cells, has transformed treatment in the past decade. Currently, over 18 million cancer survivors live in the U.S., with projections of 26 million by 2040. About 70% survive at least five years post-diagnosis, and half live ten years or more.
While cancer remains a major health challenge, these advances mean it is increasingly manageable, allowing many patients to live longer, better-quality lives. The perception of more cancer cases reflects an aging population and better detection, but it is balanced by improved outcomes and hope for patients worldwide.
